Article
Full Access
Bradykinin antagonists: Development and applications
John M. Stewart,
John M. Stewart
Department of Biochemistry, University of Colorado Medical School, Denver, Colorado 80262
Search for more papers by this authorJohn M. Stewart,
John M. Stewart
Department of Biochemistry, University of Colorado Medical School, Denver, Colorado 80262
Search for more papers by this authorAbstract
Bradykinin (BK) is involved in regulation of every major physiological system and is an initiator or mediator of many pathophysiological conditions. Rapid progress in understanding these aspects of BK biology has come since the discovery of BK antagonists. This article reviews principal points in the history of the kallikrein–kinin field and of kinin biology. The chemistry and development of antagonists for B1 and B2 kinin receptors is discussed. Uses of the antagonists in biomedical research and potential clinical applications are presented. © 1994 John Wiley & Sons, Inc.
References
- 1 Vavrek, R. J. & Stewart, J. M. (1985) Peptides 6 161–164.
- 2 Frey, E. K. (1926) Langenbecks Arch. klin. Chirurg. 142, 663.
- 3 Rocha e Silva, M., Beraldo, W. T. & Rosenfeld, G. (1949) Am. J. Physiol. 156, 261.
- 4 Elliot, D. F., Lewis, G. P. & Horton, E. W. (1960) Biochem. Diophys. Res. Commun. 3, 87–91.
- 5 Boissonnas, R. A., Guttmann, S., Jaquenoud, P. A., Konzett, H. & Sturmer, E. (1960) Experientia 16, 326.
- 6 Regoli, D., Barabe, J. & Park, W. K. (1977) Can. J. Physiol. Pharm. 55, 855–867.
- 7 Ferreira, S. H. (1965) Br. J. Pharmacol. 24, 163–169.
- 8 Ferreira, S. H., Bartelt, D. C. & Greene, L. J. (1970) Biochemistry 9, 2583–2593.
- 9 Stewart, J. M., Greene, L. J. & Ferreira, S. H. (1971) Biochem. Pharmacol. 20, 1557–1567.
- 10 Ferreira, S. H. & Vane, J. R. (1967) Br. J. Pharmacol. 30, 417–424.
- 11 Ryan, J. W., Roblero, J. & Stewart, J. M. (1968) Biochem. J. 110, 795–797.
- 12 Cushman, D. W., Cheung, H. S., Sabo, E. F., Rubin, B. & Ondetti, M. A. (1979) Fed. Proc. 38, 2778–2782.
- 13 E. G. Erdos, Ed. (1979) Handbook of Experimental Pharmacology, Springer-Verlag, New York.
- 14 Regoli, D. & Barabe, J. (1980) Pharmacol. Rev. 32, 1–46.
- 15 Bhoola, K. D., Figueroa, C. D. & Worthy, K. (1992) Pharmacol. Rev. 44, 1–80.
- 16
Dorer, F. E.,
Ryan, J. W. &
Stewart, J. M.
(1974)
Biochem. J.
14, 915–917.
10.1042/bj1410915 Google Scholar
- 17 Erdos, E. G. (1990). J. Cardiovasc. Pharmacol. 15 (Suppl. 6). 520–524.
- 18 Erdos, E. G. & Skidgel, R. A. (1989) FASEB. J. 3, 145–151.
- 19 Cuthbert, A. W. & Margolius, H. S. (1982) Br. J. Pharmacol. 75, 587–598.
- 20 Cuthbert, A. W., Evans, M. J., Colledge, W. H., MacVinish, L. J., & Ratcliff, R. (1994) Brazilian J. Med Biol. Res. 27, 1905–1910.
- 21 Smits, G. J., McGraw, D. E. & Trapani, A. J. (1990) Am. J. Physiol. 258, F1417–1424.
- 22 Benetos, A., Gavras, H., Stewart, J. M., Vavrek, R. J., Hatinoglou, S. & Gavras, I. (1986) Hypertension 8, 971–974.
- 23 Carbonell, L. F., Carreterro, O. A., Stewart, J. M. & Stewart, J. M. & Scicli, A. G. (1988) Hypertension 11. 239–243.
- 24 Yoshimura, Y., Espey, L., Hosoi, Y., Adachi, T., Atlas, S. J., Ghodgaonkar, R. B., Dubin, N. H. & Wallach, E. E. (1988) Endocrinology 122. 2540–2546.
- 25 McCormick, J. T. & Senior, J. (1974) Br. J. Pharmacol. 50, 237–241.
- 26 Dietze, G. & Wicklmayr, M. (1911) FEBS Lett. 74, 205–208.
- 27 Barnes, P. J., Chung, K. F. & Page, C. P. (1988) Pharmacol. Rev. 40, 49–85.
- 28 Steranka, L. R., Manning, D. C., DeHaas, C. J., Ferkany, J. W., Borosky, S. A., Connor, J. R., Vavrek, R. J., Stewart, J. M. & Snyder, S. H. (1988) Proc. Natl. Acad. Sci. USA 85, 3245–3249.
- 29 Kozin, F. & Cochrane, C. G. (1988) in Inflammation: Basic Principles and Clinical Correlates, J. I. Gallin, I. M. Goldstein & R. Snyderman, Eds., Raven Press, New York, pp. 101–120.
- 30 Perris, A. D. & Whitfield, J. F. (1969) Proc. Soc. Exp. Biol. Med. 130, 1198–1201.
- 31 Hambly, M. F. & Mooney, V. (1992) Spine 17, 583–585.
- 32 Makevnina, L. G., Lomova, I. P., Zubkov, Yu. N. & Semenyutin, V. B. (1994) Brazilian J. Med. Biol. Res. 27, 1955–1963.
- 33 Berg, T., Carreterro, O. A., Scicli, A. G., Tilley, B. & Stewart, J. M. (1989) Hypertension 14, 73–80.
- 34 Berguer, R., Hottenstein, O. D., Palen, T. E., Stewart, J. M. & Jacobson, E. D. (1993) Am. J. Phvsiol. 264, G492–G496.
- 35 Kangasniemi, P., Riekkinen, P., Penttinen, R., Ivaska, K. & Rinne, U. K. (1974) Headache 14, 139–148.
- 36 Miyajima, A., Miyatake, S., Schreurs, J., de Vries, J., Arai, N., Yokota, T. & Aral, K. (1988) FASEB J. 2, 2462.
- 37 Abraham, W. M., Burch, R. M. & Farmer, S. G. (1991) Am. Rev. Respir. Dis. 143, 787–796.
- 38 Proud, D. & Kaplan, A. P. (1988) Ann. Rev. Immunol. 6, 49–83.
- 39 Lauredo, I. T. & Abraham, W. M. (1991) FASEB J. 5, A547.
- 40 Togias, A., Naclerio, R. M., Proud, D., Pipkorn, U., Bascom, R., Iliopoulos, O., Kagey-Sobotka, A., Norman, P. S. & Liechtenstein, L. M. (1988) J. Allergy Clin. Immunol. 81, 782–790.
- 41 Davis, A. E., III. (1988). Ann. Rev. Immunol. 6, 595–628.
- 42 Molla, A., Yamamoto, T., Akaike, T., Miyoshi, S. & Maida, H. (1989) J. Biol. Client. 264. 10589–10594.
- 43 Maeda, H., Akaike, T., Sakata, Y. & Maruo, K. (1993) in Proteases. Protease Inhibitors and Protease-Derived Peptides. J. C. Cheronis & J. E. Repine, Eds., Birkhauser Yerlag. Basel, pp. 159–165.
- 44
Lembeck, F.
(1987) in
Substance P and, Neurokinins.
J. L. Henry,
R. Couture,
A. C. Cuello,
G. Pelletier,
R. Quirion &
D. Regoli, Eds.,
Springer-Verlag, New York.
pp. 380–387.
10.1007/978-1-4612-4672-5_124 Google Scholar
- 45 Oyvin, I. A. Gaponyuk, P. Y., Oyvin, V. I. & Tokarev, O. Y. (1970) Experientia 26, 843–844.
- 46 Gonias, S. L., Swaim, M. W., Massey, M. F. & Pizzo, S. V. (1988) J. Biol. Chem. 263, 393.
- 47
Simon, S. R.
(1993)in
Proteases. Protease Inhibitors and Protease-Derived Peptides,
J. C. Cheronis &
J. E. Repine, Eds.,
Birkhauser Verlag, Basel,
pp. 27–37.
10.1007/978-3-0348-7397-0_3 Google Scholar
- 48 Whalley, E. T., Nwator, I. A., Stewart, J. M. & Vavrek, R. J. (1987) Naunyn-Schmiedeberg's Arch. Pharmacol. 336, 430–433.
- 49 Liebmann, C. Schnittler, M., Stewart, J. M. & Reissmann, S. (1991) Eur. J. Pharmacol. 199, 363–365.
- 50 Farmer, S. G. & Burch, R. M. (1992) Ann. Rev. Pharmacol. Toxicol. 32, 511–536.
- 51 Dray, A. & Perkins, M. (1993) Trends Neurosci. 16, 99–104.
- 52 Perkins, M. N., Campbell, E. & Dray, A. (1993) Pain 53, 191–197.
- 53 Regoli, D., Rhaieb, N.-E., Drapeau, G. & Dion, S. (1990) J. Cardiovasc. Pharmacol. 15, S30–S38.
- 54 McEachern, A. E., Shelton, E. R., Bhakta, S., Obernolte, R., Bach, C., Zuppan, P., Fujisaki, J., Aldrich, R. W. & Jarnagin, K. (1991) Proc. Natl. Acad. Sci. USA 88, 7724–7728.
- 55 Hess, J. F., Borkowski, J. A., Young, G. S., Strader, C. D. & Ransom, R. W. (1992) Biochem. Biophys. Res. Commun. 184, 260–268.
- 56 Eggerickx, D., Raspe, E., Bertrand, D., Vassart, G., & Parmentier, M. (1992) Biochem. Biophys. Res. Commun. 187, 106–1313.
- 57 Powell, S. J., Slynn, G., Thomas, C. Hopkins, B., Briggs, I. & Graham, A. (1993) Genomics 15, 435–438.
- 58 Freedman, R. & Jarnagin, K. (1992) in Proteases. Protease Inhibitors and Protease-Derived Peptides. H. Fritz, W. Muller-Esterl, M. Jochum, A. Roscher & K. Luppertz, Eds., Birkhauser Verlag, Basel, pp. 487–496.
- 59 Park, J., Frecdrnan, R., Bach, C., Yee, C., Rohrwild, M., Kaminishi, H., Muller-Esterl, W., & Jarnagin, K. (1994) Brazilian J. Med. Biol. Res. 27, 1707–1724.
- 60 Mclntyre, P., Phillips, E., Skidmore, E., Brown, M. & Webb, M. (1993) Mol. Pharmacol. 44, 346–355.
- 61 Bueb, J.-L., Mousli, M., Bronner, C. Rouot, B. & Landry, Y. (1991) Mol. Pharmacol. 38, 816–822.
- 62 Monacada, S., Palmer, R. M. S. & Higgs, E. A. (1991) Pharmacol. Rev. 43, 109–142.
- 63 Ljunggren, O., Vavrek, R. J., Stewart, J. M. & Lerner, U. H. (1991) Bone Mineral Res. 6, 807–815.
- 64
J. Kurjan &
B. L. Taylor, Eds.
(1993)
Signal Transduction
Academic Press, San Diego, CA.
10.1016/B978-0-12-429350-2.50009-7 Google Scholar
- 65 Dray, C. A., Bettancy, J., Forster, P. & Perkins, M. N. (1988) Keurosci. Lett. 91, 301–307.
- 66 Stewart, J. M. & Vavrek, R. J. (1990) in Bradykinin Antagonists. R. M. Burch, Ed., Pergamon, Oxford, pp. 51–96.
- 67 Dunn, F. W. & Stewart, J. M. (1971) J. Med. Chem. 14, 779–781.
- 68 Sasaguri, M., Ikeda, M., Ideiski, M. & Arakawa, K. (1988) Biochem. Biophys. Res. Commun. 150, 511–516.
- 69 Togo, J., Burch, R. M., DeHaas, J., Connor, J. R. & Steranka, L. R. (1989) Peptides 10, 109–112.
- 70 Regoli, D., Drapeau, G., Rovero, P., Dion, S. & D'Orleans-Juste, P. (1986) Eur. J. Pharmacol. 123, 61–66.
- 71 Lembeck, F., Griesbacher, T., Eckhardt, M., Menke, S., Breipohl, G. & Knolle, J. (1991) Br. J. Pharmacol. 102, 297–304.
- 72 Cheronis, J. C., Whalley, E. T., Nguyen, K. T., Eubanks, S. R., Allen, L. G., Duggan, M. J., Loy, S. D., Bonham, K. A. & Blodgett, J. K. (1992) J. Med. Chem. 35. 1563–1572.
- 73 Cheronis, J. C. Whalley, E. T., Allen, L. G., Loy, S. D., Elder, M. W., Duggan, M. J., Gross, K. L. & Blodgett, J. K. (1994) J. Med. Chem. 37, 348–355.
- 74 Lammek, B., Wang, Y.-X., Gavras, I. & Gavras, H. (1991) J. Pharm. pharmacol. 43, 887–888.
- 75 Devillier, P., Drapeau, G., Renoux, M. & Regoli, D. (1989) Eur. J. Pharmacol. 168, 53–60.
- 76 R. M. Burch, Ed. (1991) Bradykinin Antagonists. Dekker, New York.
- 77 Bathon, J. M. & Proud, D. (1991). Ann. Rev. Pharmacol. Toxicol. 31, 129–162.
- 78 Regoli, D. & Barabe, J. (1980) Pharmacol. Rev. 32, 1–46.
- 79 Burch, R. M., Kyle, D. J. & Stormann, T. M. (1993) Molecular Biology and Pharmacology of Bradykinin Receptors. R. G. Landes Co., Austin. TX.
- 80 Farmer, S. G., Burch, R. M., Meeker, S. A. & Wilkins, D. E. (1989) Mol. Pharmacol. 36, 1–8.
- 81 Saha, J. K., Sengupta, J. N. & Goyal, R. K. (1991) J. Pharmacol. Exp. Ther. 259, 265–273.
- 82 Pyne, S. & Pyne, N. J. (1993) Br. J. Pharmacol. 110, 477–481.
- 83 Burch, R. M. & Kyle, D. J. (1992) Life. Sci. 50, 829–838.
- 84 Snider, R. M., Constantine, J. W., Lowe, J. A., III, Longo, K. P., Lebel, W. S., Woody, H. A., Drozda, S. E., Desai, M. C., Vinick, F. J., Spencer, R. W. & Hess, H. J. (1990) Science 251, 435–437.
- 85 Dhanoa, D. S., Bagley, S. W., Chang, R. S. L., Lotti, V. J., Chen, T.-B., Kivlighn, S. D., Zingaro, G. J., Siegl, P. K. S., Patchett, A. A. & Greenlee, W. J. (1993) J. Med. Chem. 36, 4230–4238.
- 86 Yamamura, Y., Ogawa, H., Chihara, T., Kondo, K., Onogawa, T., Nakamura, S., Mori, T., Tominaga, M. & Yabuuchi, Y. (1991) Science 252, 572–574.
- 87 Bock, M. G., DiPardo, R. M., Evans, B. E., Rittle, K. E., Whitter, W. L., Garsky, V. M., Gilbert, K. F., Leighton, J. L., Carson, K. L., Mellin, E. C., Veber, D. F., Chang, R. S. L., Lotti, V. J., Freedman, S. B., Smith, A. J., Patei, S., Anderson, P. S. & Freidinger, R. M. (1993) J. Med. Chem. 36, 4276–4292.
- 88 Clozel, M., Breu, V., Burri, K., Cassal, J.-M., Fischli, W., Gray, G. A., Hirth, G., Löffler, B.-M., Muller, M., Neidhart, W. & Ramuz, H. (1993) Nature 365, 759–761.
- 89 Salvino, J. M., Seoane, P. R., Douty, B. D., Awad, M. M. A., Dolle, R. E., Houck, W. T., Faunce, D. M. & Sawuiz, D. G. (1993) J. Med. Chem. 36, 2583–2584.
- 90 Ellis, E. F., Heizer, M. L., Hambrecht, G. S., Holt, S. A., Stewart, J. M. & Vavrek, R. J. (1987) Stroke 18, 792–795.
- 91 Whalley, E. T., Solomon, J. A., Madafleri, D. M., Bonham, K. A. & Cheronis, J. C. (1992) in Recent Progress on Kinins., G. Bonner, H. Fritz, B. Schoelkens, G. Dietze & K. Lupetz, Eds., Birkhauser, Basel, pp. 413–420.
- 92 Lowe, V. C., Kyle, D. J., Hiner, R. N., Martin, J. A., Burch, R. M. & Noronha-Blob, L. (1992) in Am. Fed. Clin. Res. Abstracts.
- 93 Griesbacher, T. & Lembeck, F. (1992) Br. J. Pharmacol. 107, 356–360.
- 94 Neugebauer, V., Schaible, H. G. & Schmidt, R. F. (1989) Pfluegers Arch. 415, 330–335.
- 95 Note added in proof. The cloning and amino acid sequence of a human bradykinin B1 receptor has just been published: Menke, J. G., Borkowski, J. A., Bierilo, K. K., MacNeil, T., Derrick, A. W., Schneck, K. A., Ransom, R. W., Strader, C. D., Lincmeyer, D. L., & Hess, J. F. (1994) J. Biol. Chem. 269, 21583–21586.
